News

Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug competition
Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...
Who is Maziar Mike Doustdar? Novo Nordisk names new CEO to tackle ‘market challenges’
Novo Nordisk has appointed Maziar Mike Doustdar as CEO, replacing Lars Fruergaard, to address recent market challenges.
Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook
Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...
NVO stock: Why did Novo Nordisk shares drop 20% today—and who is Maziar Mike Doustdar?
Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...
Ozempic maker crashes as it loses battle of the fat jabs
Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...
Can Ozempic cause depression?
Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...
Novo Nordisk Bets Big on India, creates new jobs
Novo Nordisk has launched its anti-obesity drug Wegovy in India, which has become a key market for the company. Having ...
In Ozempic’s home town they fear two things: a new set of tariffs, and a company in Kinsale
The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...